SCHEMBL290982

SCHEMBL290982

C[CH]OCC(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8536219 0.73
SCHEMBL3317451 0.71
SCHEMBL1148901 0.71
SCHEMBL1825 0.69
SCHEMBL11700212 0.69
SCHEMBL128361 0.69
SCHEMBL10979113 0.69
SCHEMBL9753838 0.67 THRB (0.32)
SCHEMBL9119600 0.65
SCHEMBL3317222 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649135-B1 SYNTHESIS OF HALICHONDRINS HARVARD COLLEGE (US) 2022-12-28 EP claimed
EP-0605638-B1 METAL ALKOXIDES UNIV FLORIDA STATE (US) 1999-09-01 EP claimed
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 US disclosed
US-20240199602-A1 INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-06-20 US disclosed
WO-2024123978-A1 IONIZABLE LIPIDS WITH MALONATE TAILS MODERNATX, INC. (US) 2024-06-13 WO disclosed
US-20240181067-A1 TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-06-06 US disclosed
EP-4377306-A1 ROCK2 INHIBITORS AND USES THEREOF President and Fellows of Harvard College (US) 2024-06-05 EP disclosed
US-20240174637-A1 DEGRADERS OF GRK2 AND USES THEREOF PIIZZI GRAZIA (US) 2024-05-30 US disclosed
US-20240174616-A1 HDAC6 INHIBITORS AND USES THEREOF EIKONIZO THERAPEUTICS, INC. (US) 2024-05-30 US disclosed
WO-2024112854-A1 INHIBITORS OF RIPK2 AND MEDICAL USES THEREOF ODYSSEY THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed
WO-2024097948-A1 DEGRADERS OF MDM2 AND USES THEREOF ROIVANT DISCOVERY, INC. (US) 2024-05-10 WO disclosed
US-20060128669-A1 Heterocyclic compounds having inhibitory activity against hiv integrase SHIONOGI & CO., LTD. (JP) 2006-06-15 US disclosed
EP-1541558-A1 HETEROCYCLIC COMPOUND HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2005-06-15 EP disclosed
US-20040229909-A1 Antiviral agent SHIONOGI & CO., LTD. (JP) 2004-11-18 US disclosed
US-20040127708-A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity SHIONOGI & CO., LTD. (JP) 2004-07-01 US disclosed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP disclosed
EP-1375486-A1 NITROGEN-CONTAINING HETEROARYL COMPOUNDS HAVING HIV INTEGRASE INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2004-01-02 EP disclosed
EP-0690853-A4 TAXANES PREPARED BY BETA-LACTAMS AND AMMONIUM ALKOXIDES UNIV FLORIDA STATE (US) 1996-03-27 EP disclosed
EP-0690853-A1 TAXANES PREPARED BY BETA-LACTAMS AND AMMONIUM ALKOXIDES FLORIDA STATE UNIVERSITY (US) 1996-01-10 EP disclosed
WO-1994021623-A1 TAXANES PREPARED BY BETA-LACTAMS AND AMMONIUM ALKOXIDES FLORIDA STATE UNIVERSITY (US) 1994-09-29 WO disclosed